Clinical trial
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department
NCT01660867 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- August 31, 2012
- Completion date
- December 31, 2014
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute bronchiolitis